Selectis HealthGBCS -0.61%45 Days Payable is 101.13 as of Mar. 2026, which is 35% above its 10-year median of 74.89. GuruFocus rates GBCS with a GF Score™ of 45/100 and a GF Value™ of $2.14 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 606 Healthcare Providers & Services companies, Selectis Health ranks better than 66.34% on this metric.
The historical rank and industry rank for Selectis Health's Days Payable or its related term are showing as below:
GBCS'
s Days Payable Range Over the Past 10 Years
Min: 49.07 Med: 74.89 Max: 486.81
Current: 90.07
During the past 13 years, Selectis Health's highest Days Payable was 486.81. The lowest was 49.07. And the median was 74.89.
GBCS's Days Payable is ranked better than 66.34% of 606
companies
in the Healthcare Providers & Services industry
Industry Median: 58.205
vs GBCS: 90.07
Selectis Health's Days Payable
increased
from Mar. 2025 (82.85) to Mar. 2026 (101.13).
It may suggest that Selectis Healthdelayed paying its suppliers.
Selectis Health Days Payable Related Terms
Selectis Health Days Payable Historical Data
* Premium members only.
The historical data trend for Selectis Health's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Selectis Health's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Selectis Health Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Selectis Health's Days Payable distribution charts can be found below:
* The bar in red indicates where Selectis Health's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Selectis Health's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Selectis Health (GBCS) has a Days Payable of 101.13 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Selectis Health and its competitors. This is 35% above median its historical median of 74.89. Over the past decade, Selectis Health's Days Payable has ranged from 49.07 to 486.81. According to the industry distribution chart, Selectis Health ranks #204 out of 606 companies in the Healthcare Providers & Services industry, placing it in the top 33.7%.
Is Selectis Health's Days Payable too high?
Selectis Health's current Days Payable of 101.13 is 35% above median its 10-year median of 74.89. Over the past 10 years, this metric has ranged from a low of 49.07 to a high of 486.81. The Healthcare Providers & Services industry median Days Payable is 58.21. Selectis Health's value of 101.13 is 73.7% above this industry median. Based on the distribution chart, Selectis Health ranks #204 out of 606 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Selectis Health has a GF Score™ of 45/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Selectis Health's Days Payable compare to CCM and BMGL?
According to the Healthcare Providers & Services industry distribution chart, Selectis Health ranks #204 out of 606 companies for Days Payable. This puts Selectis Health in the upper half of its industry. The industry median Days Payable is 58.21. Selectis Health's value of 101.13 is 73.7% above this benchmark. Historically, Selectis Health's own Days Payable has ranged from 49.07 to 486.81 over the past decade. While the company's 10-year median is 74.89 vs. the industry median of 58.21, Selectis Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.21, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Selectis Health's current Days Payable of 101.13 is 73.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Selectis Health and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Selectis Health's current Days Payable is 101.13, which is 35% above median its own 10-year median of 74.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Selectis Health stock overvalued right now?
Based on GuruFocus' analysis, Selectis Health (GBCS) is currently considered Significantly Overvalued. The stock's GF Value™ is $2.14, compared to a current price of $5.20 — trading 143% above its estimated fair value. The current Days Payable is 101.13, which is 35% above median its 10-year median of 74.89 and 73.7% above the Healthcare Providers & Services industry median of 58.21. Selectis Health's overall GF Score™ is 45/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Selectis Health (GBCS), the current Days Payable is 101.13 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Selectis Health (GBCS) Overvalued in 2026?
Based on GuruFocus' analysis, Selectis Health stock appears to be overvalued.
The current stock price of $5.20 is trading 143% above its estimated GF Value™ of $2.14.
GuruFocus considers Selectis Health to be Significantly Overvalued.
Key valuation signals for GBCS:
Days Payable: 101.13 (35% above median its 10-year median of 74.89)
GF Value™: $2.14 vs. price of $5.20 (143% above fair value)
Industry Position: 73.7% above the Healthcare Providers & Services median (#204 of 606)
No single metric tells the full story. See the GBCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Selectis Health Inc owns and operates medical care facilities in the healthcare industry. The company acquires, develops, leases, and manages healthcare real estate and provides healthcare operations through its wholly-owned subsidiaries. The portfolio is comprised of investments in the following healthcare operations: (i) senior housing (including independent and assisted living) and (ii) post-acute/skilled nursing. It makes investments within the healthcare operations using the following six investment products: (i) direct ownership of properties, (ii) debt investments, (iii) developments and redevelopments, (iv) investment management, (v) the Housing and Economic Recovery Act of 2008, which represents investments in senior housing operations, and (vi) owning healthcare operations.
45GF Score
Get the complete analysis for GBCS
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GBCS has been successfully added to your 
